Antibiotic resistance amongst healthcare-associated pathogens in China

详细信息    查看全文

• 作者：Saber Yezli ; Han Li
• 关键词：Mycobacterium tuberculosis ; Gram-positive organisms ; Gram-negative organisms ; Multidrug-resistant ; China
• 刊名：International Journal of Antimicrobial Agents
• 出版年：2012
• 出版时间：November, 2012
• 年：2012
• 卷：40
• 期：5
• 页码：389-397
• 全文大小：331 K

文摘

The People's Republic of China, commonly known as China, comprises approximately one-fifth of the world's population. Because of the expanding size and density of its population and the frequent interaction of people with animals, China is a hotspot for the emergence and spread of new microbial threats and is a major contributor to the worldwide infectious disease burden. In recent years, the emergence and rapid spread of severe acute respiratory syndrome (SARS) generated considerable interest in the Chinese healthcare system and its infection control and prevention measures. This review examines antibiotic misuse and the status of antibiotic resistance in the Chinese healthcare system. China has high rates of antibiotic resistance driven by misuse of these agents in a healthcare system that provides strong incentives for overprescribing and in a country where self-medication is common. Tuberculosis remains a serious problem in China, with a high prevalence of multidrug-resistant and extensively drug-resistant strains. Drug resistance amongst nosocomial bacteria has been on a rapid upward trend with a strong inclination towards multidrug resistance. There is a need for effective infection prevention and control measures and strict use of antibiotics in China to control the rise and spread of antibiotic resistance in the country.